Lyell Immunopharma Ownership | Who Owns Lyell Immunopharma?
Lyell Immunopharma Ownership Summary
Lyell Immunopharma is owned by 70.06% institutional investors, 35.44% insiders. Arch venture management is the largest institutional shareholder, holding 19.00% of LYEL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.84% of its assets in Lyell Immunopharma shares.
LYEL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lyell Immunopharma | 70.06% | 35.44% | -5.49% |
| Sector | Healthcare Stocks | 35.56% | 12.08% | 52.36% |
| Industry | Biotech Stocks | 35.43% | 12.01% | 52.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Arch venture management | 3.25M | 19.00% | $65.14M |
| Gsk | 1.51M | 8.85% | $30.34M |
| Blackrock | 13.50M | 5.31% | $19.57M |
| Vanguard group | 826.43K | 4.52% | $25.44M |
| Orland properties | 754.70K | 4.42% | $15.14M |
| Almitas capital | 577.81K | 3.38% | $11.59M |
| Wuxi apptec | 7.68M | 3.02% | $11.14M |
| Foresite capital management v | 477.08K | 2.79% | $9.57M |
| Millennium management | 458.90K | 2.68% | $9.21M |
| Citadel advisors | 381.46K | 2.23% | $7.65M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Wuxi apptec | 7.68M | 47.74% | $11.14M |
| Arch venture management | 3.25M | 9.62% | $65.14M |
| Orland properties | 754.70K | 5.67% | $15.14M |
| Gsk | 1.51M | 5.06% | $30.34M |
| Foresite capital management v | 477.08K | 3.53% | $9.57M |
| Almitas capital | 577.81K | 2.62% | $11.59M |
| Venbio partners | 337.70K | 2.41% | $6.77M |
| Takeda pharmaceutical | 41.16K | 1.86% | $363.91K |
| Decheng capital | 595.47K | 1.33% | $5.26M |
| Velan capital investment management lp | 102.00K | 1.28% | $2.05M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| D. e. shaw | 966.26K | 0.00% | 493.64K |
| Arch venture management | 3.25M | 9.62% | 488.09K |
| Millennium management | 458.90K | 0.00% | 400.25K |
| Wellington management group llp | 367.68K | 0.00% | 367.68K |
| Velan capital investment management lp | 102.00K | 1.28% | 102.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Decheng capital | 595.47K | 1.33% | -11.31M |
| Balyasny asset management | - | - | -1.20M |
| Mwg management | - | - | -1.01M |
| Invenomic capital management lp | - | - | -871.52K |
| Foresite capital management iv | - | - | -800.40K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Wellington management group llp | 367.68K | 0.00% | 367.68K | $533.13K |
| Velan capital investment management lp | 102.00K | 1.28% | 102.00K | $2.05M |
| Vanguard fiduciary trust | 86.92K | 0.00% | 86.92K | $1.74M |
| Opaleye management | 79.10K | 0.21% | 79.10K | $1.59M |
| Dimensional fund advisors lp | 47.89K | 0.00% | 47.89K | $959.00K |
Sold Out
| Holder | Change |
|---|---|
| Eversource wealth advisors | -1.00 |
| Pnc financial services group | -4.00 |
| True wealth design | -23.00 |
| Nelson, van denburg & campbell wealth management group | -34.00 |
| Allworth financial lp | -43.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 76 | 8.57% | 11,974,545 | 4.99% | 70 | 1.80% | 43 | 34.38% | 9 | -47.06% |
| Dec 31, 2025 | 10 | -82.76% | 864,633 | -91.03% | 4 | 0.11% | 4 | -80.00% | 2 | -89.47% |
| Sep 30, 2025 | 15 | -78.26% | 1,180,540 | -87.25% | 7 | 0.20% | 6 | -50.00% | 4 | -92.86% |
| Jun 30, 2025 | 68 | -39.82% | 9,256,423 | -93.92% | 62 | 939.01% | 12 | -68.42% | 55 | 52.78% |
| Mar 31, 2025 | 112 | 8.74% | 152,309,719 | 1.35% | 51 | 1.50% | 38 | -26.92% | 37 | 48.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 604.46K | 2.84% | 67.20K |
| Vanguard Morn Total Stk Mkt Idx Investor | 604.46K | 2.47% | 67.20K |
| T. Rowe Price Health Sciences | 212.18K | 1.10% | -2.38K |
| Biotech Growth Ord | 2.88M | 0.99% | - |
| iShares Russell 2000 ETF | 222.04K | 0.95% | -3.94K |
| Vanguard Small Cap Index | 2.24M | 0.87% | 5.37K |
| Vanguard Institutional Extnd Mkt Idx Tr | 163.75K | 0.77% | - |
| Vanguard Small Cap Growth Index Inv | 1.25M | 0.49% | -5.54K |
| Fidelity Small Cap Index | 1.63M | 0.44% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 1.18M | 0.40% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 10, 2026 | Bulis Veronica Sanchez | VP, Corporate Controller | Sell | $8.91K |
| Aug 10, 2026 | Lee Gary K. | Chief Scientific Officer | Sell | $1.88K |
| Aug 10, 2026 | Hill Stephen J. | Chief Operating Officer | Sell | $1.28K |
| Aug 10, 2026 | Seely Lynn | President and CEO | Sell | $5.59K |
| Jul 17, 2026 | Innovative Cellular Therapeutics Holdings Ltd | - | Sell | $137.00 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q3 | - | 6 |
| 2026 Q2 | - | 5 |
| 2026 Q1 | 2 | 7 |
| 2025 Q4 | - | 6 |
| 2025 Q3 | - | 12 |
LYEL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools